Healthcare Realty Trust (NYSE:HR) Sees Unusually-High Trading Volume Following Analyst Upgrade

Key Points

• Healthcare Realty Trust (HR) saw unusually-high trading volume of about 10.2 million shares (a 185% increase) after Cantor Fitzgerald raised its price target to $22 and maintained an overweight rating, with the stock trading near $19.80.
• The REIT beat Q1 EPS estimates ($0.41 vs. $0.39) while revenue declined 7.7% year-over-year, and management set FY 2026 guidance of $1.59–$1.65 per share (consensus ~1.61).
• The company declared a quarterly dividend of $0.24 (annualized $0.96, ~4.8% yield, ex-dividend May 11), and Director Thomas Bohjalian bought 10,000 shares at about $18.09, increasing his stake to 85,520 shares.

Healthcare Realty Trust Incorporated (NYSE:HR - Get Free Report) shares saw unusually-strong trading volume on Tuesday after Cantor Fitzgerald raised their price target on the stock from $21.00 to $22.00. Cantor Fitzgerald currently has an overweight rating on the stock. Approximately 10,197,319 shares traded hands during trading, an increase of 185% from the previous session's volume of 3,580,217 shares.The stock last traded at $19.7980 and had previously closed at $19.58.

Other equities research analysts also recently issued research reports about the company. UBS Group initiated coverage on shares of Healthcare Realty Trust in a report on Monday, April 20th. They issued a "neutral" rating and a $18.00 price objective for the company. Wall Street Zen upgraded shares of Healthcare Realty Trust from a "sell" rating to a "hold" rating in a report on Saturday, January 31st. Finally, Weiss Ratings reissued a "hold (c)" rating on shares of Healthcare Realty Trust in a research report on Friday, March 27th. Three investment analysts have rated the stock with a Buy rating, six have given a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the stock presently has an average rating of "Hold" and an average price target of $19.25.

Insider Transactions at Healthcare Realty Trust

In other Healthcare Realty Trust news, Director Thomas N. Bohjalian bought 10,000 shares of Healthcare Realty Trust stock in a transaction dated Friday, March 6th. The stock was acquired at an average cost of $18.09 per share, with a total value of $180,900.00. Following the completion of the acquisition, the director owned 85,520 shares of the company's stock, valued at approximately $1,547,056.80. This represents a 13.24% increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 0.56% of the company's stock.

Hedge Funds Weigh In On Healthcare Realty Trust

Several institutional investors and hedge funds have recently added to or reduced their stakes in HR. Wiser Advisor Group LLC purchased a new stake in shares of Healthcare Realty Trust during the 3rd quarter worth approximately $25,000. Smartleaf Asset Management LLC boosted its stake in shares of Healthcare Realty Trust by 179.7% during the 3rd quarter. Smartleaf Asset Management LLC now owns 1,608 shares of the real estate investment trust's stock worth $29,000 after purchasing an additional 1,033 shares during the last quarter. Atlantic Union Bankshares Corp purchased a new position in shares of Healthcare Realty Trust during the 3rd quarter worth $32,000. Eurizon Capital SGR S.p.A. purchased a new position in shares of Healthcare Realty Trust during the 4th quarter worth about $37,000. Finally, Prosperity Bancshares Inc purchased a new position in shares of Healthcare Realty Trust during the 4th quarter worth about $42,000.

Healthcare Realty Trust Price Performance

The business's 50-day simple moving average is $18.00 and its two-hundred day simple moving average is $17.69. The stock has a market capitalization of $6.94 billion, a price-to-earnings ratio of -34.24 and a beta of 0.97.

Healthcare Realty Trust (NYSE:HR - Get Free Report) last announced its earnings results on Thursday, April 30th. The real estate investment trust reported $0.41 earnings per share for the quarter, beating the consensus estimate of $0.39 by $0.02. Healthcare Realty Trust had a negative net margin of 17.34% and a negative return on equity of 4.29%. The business had revenue of $275.28 million during the quarter, compared to the consensus estimate of $283.01 million. During the same period in the prior year, the firm earned $0.39 earnings per share. The business's quarterly revenue was down 7.7% compared to the same quarter last year. Healthcare Realty Trust has set its FY 2026 guidance at 1.590-1.65 EPS. As a group, sell-side analysts expect that Healthcare Realty Trust Incorporated will post 1.61 EPS for the current year.

Healthcare Realty Trust Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, May 22nd. Investors of record on Monday, May 11th will be given a dividend of $0.24 per share. This represents a $0.96 annualized dividend and a dividend yield of 4.8%. The ex-dividend date of this dividend is Monday, May 11th. Healthcare Realty Trust's dividend payout ratio is currently -165.52%.

Healthcare Realty Trust Company Profile

Healthcare Realty Trust NYSE: HR is a real estate investment trust specializing in the ownership, acquisition and management of outpatient medical facilities. Headquartered in Nashville, Tennessee, the company's portfolio is focused primarily on medical office buildings and outpatient healthcare properties that serve hospitals, health systems and other healthcare providers. Its business model centers on securing long-term, triple-net leases to generate stable income streams from a diversified tenant base.

The company's properties are located across key metropolitan markets in the United States, including major healthcare hubs in the Southeast, Southwest and in select coastal regions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.